Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back.

about

SR-16234, a Novel Selective Estrogen Receptor Modulator for Pain Symptoms with Endometriosis: An Open-label Clinical Trial.New insights on the pathogenesis of endometriosis and novel non-surgical therapies

P2860

Q49407072-BFD934EA-1FE1-4599-ABEE-0DDB2475BD05 Q58799203-3F44ED59-3C43-4A92-8ED8-F5FD57EF0897

P2860

Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back.

Item

http://www.wikidata.org/entity/Q35889671

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Reduction in Endometrioma Size ...... bition and Progestin Add-Back.

@ast

Reduction in Endometrioma Size ...... bition and Progestin Add-Back.

@en

type

Item

label

Reduction in Endometrioma Size ...... bition and Progestin Add-Back.

@ast

Reduction in Endometrioma Size ...... bition and Progestin Add-Back.

@en

prefLabel

Reduction in Endometrioma Size ...... bition and Progestin Add-Back.

@ast

Reduction in Endometrioma Size ...... bition and Progestin Add-Back.

@en

P1476

Reduction in Endometrioma Size ...... bition and Progestin Add-Back.

@en

P2093

Warren G Foster

http://www.w3.org/2001/XMLSchema#string

P2860

Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target.

Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis.

Late manifestation of pelvic abscess following oocyte retrieval, for in vitro fertilization, in patients with severe endometriosis and ovarian endometriomata.

Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels.

Endometriosis: cost estimates and methodological perspective.

Pelvic abscess after oocyte retrieval in women with endometriosis: A case series.

Aromatase inhibitors in recurrent ovarian endometriomas: report of five cases with literature review.

Treatment of severe postmenopausal endometriosis with an aromatase inhibitor.

Effects of excision of ovarian endometrioma on the antral follicle count and collected oocytes for in vitro fertilization.

Economic burden of surgically confirmed endometriosis in Canada.

P304

878517

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/878517

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Sanjay Agarwal

P577

2015-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280870625

http://www.w3.org/2001/XMLSchema#string

P698

26247030

http://www.w3.org/2001/XMLSchema#string

P932

4515259

http://www.w3.org/2001/XMLSchema#string

Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back.

about

P2860

P2860

Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932